Normal view MARC view ISBD view

3D QSAR Studies on DAPY'S (Diaryl Pyrimidines) and CAPY’S (Cycloalkyl-Aryl Pyrimidines) as HIV-1 Reverse Transcriptase Inhibitors Using CoMFA & CoMSIA Approaches

By:

Material type: Film

FilmPublication details: Ahmedabad Institute of Pharmacy, Nirma University 2015Description: 56pDDC classification:

Online resources:

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

Holdings
Item type	Current library	Collection	Call number	Status	Notes	Date due	Barcode	Item holds
CD/DVD	NIMA Knowledge Centre Reference	Reference	615.19 SHA (Browse shelf(Opens below))	Not For Loan	Project Report CD		PPR00563

Total holds: 0

Previous	No cover image available	No cover image available	No cover image available	No cover image available	No cover image available	No cover image available	No cover image available	Next
Previous	615.19 SHA Computer-Aided Drug Design and Development of Anti-Tubercular Agents as a Multi-Target Inhibitors	615.19 SHA Histone Deacetylase : A Target for Cancer Therapy	615.19 SHA 3D QSAR Study on Azaindole Hydroxamic Acids as HIV-1 Integrase Inhibitors	615.19 SHA 3D QSAR Studies on DAPY'S (Diaryl Pyrimidines) and CAPY’S (Cycloalkyl-Aryl Pyrimidines) as HIV-1 Reverse Transcriptase Inhibitors Using CoMFA & CoMSIA Approaches	615.19 SHA Design, Development and Characterization of Ophthalmic Nanoemulsion using Microfluidizer as a Technology	615.19 SHA Design, Development and Characterization of Ophthalmic Nanoemulsion using Microfluidizer as a Technology	615.19 SHA Formulation Development of Extended Release Capsule for the Treatment of Parkinson's Disease	Next

Guided by Dr. Hardik G. Bhatt

There are no comments on this title.

to post a comment.